News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Evotec AG Reports Strong Third Quarter 2008 and Improves Full-Year Guidance
November 14, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HAMBURG, Germany, Nov. 14, 2008 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC) today reported results for the third quarter and nine months ended September 30, 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Deals
Sun Pharma beams up Organon in $11.75B acquisition
April 27, 2026
·
1 min read
·
Gabrielle Masson
Deals
Lilly lands third oncology deal in 3 weeks, inking up to $2.3B for Ajax
April 27, 2026
·
2 min read
·
Gabrielle Masson
Funding
Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases
April 27, 2026
·
2 min read
·
Tristan Manalac
Drug pricing
J&J puts blockbuster blood thinner Xarelto on TrumpRx
April 27, 2026
·
2 min read
·
Tristan Manalac